Aerosolized and Intravenous Colistin in Healthy Adults

NCT01863719 · clinicaltrials.gov ↗

PHASE1

Phase

TERMINATED

Status

27

Enrollment

NIH

Sponsor class

Stopped Completion of cohort 3, safety concerns

Conditions

Pathogen Resistance
Pneumococcal Infection
Pneumonia

Interventions

DRUG: Colistimethate sodium
DRUG: Colistimethate sodium

Sponsor

National Institute of Allergy and Infectious Diseases (NIAID)